[ Price : $8.95]
FDA approves labeling changes for Haleons OTC weight loss drug alli to warn of the rare risk of kidney injury associated with its ...[ Price : $8.95]
The United States Pharmacopoeia 2025 annual drug shortage report documents a reduction in the number of drug shortages but an incr...[ Price : $8.95]
A Windels Marx petition asks FDA not to approve any ANDA for dabrafenib mesylate using the 505(j)(2)(C) pathway that doesnt includ...[ Price : $8.95]
A Health Affairs article discusses clarifications and revisions that it says are needed in an FDA draft guidance describing a plau...[ Price : $8.95]
Three Akin Gump attorneys highlight some changes in a 2026 FDA draft guidance on communicating healthcare economic information fro...[ Price : $8.95]
FDA extends the comment period by 30 days for its request for information on drug repurposing for unmet medical needs.[ Price : $8.95]
FDA approves an expanded dosing regimen for Lillys atopic dermatitis treatment Ebglyss (lebrikizumab-lbkz), allowing certain patie...[ Price : $8.95]
FDA sends an untitled letter to contract manufacturer Formulated Solutions, citing GMP violations related to component testing and...